Monday, May 23, 2022

Day 843: Boosting Severity

The bad cat counts up adverse effects of boosters in VAERS and finds them even deadlier than the original shots:
the surge of boosters in the US began in September 2021.

this is precisely the same time the spike in deaths and hospitalizations per day per dose per day started.

so this is NOT an artifact of just dosing more, we’ve already controlled for that. the per dose incidence of death and hospitalization rose 4X immediately, seems to have plateaued for a minute, then found another step function spike in late january early feb and basically increased 5X from its already 5X elevated level. that is actual exponential growth in propensity for severe bad outcomes per dose.

such a thing is extremely unusual to see and would appear to be of such magnitude as to make a simple rise in reporting rates appear highly unlikely, especially as the overall reports figure does not mirror this pattern, retains linearity, and shows no major moves during this spike in more severe outcomes.

[...]

VAERS is supposed to function as a tripwire, a warning system. it’s the canary in the vaccine coal mine.

american public health officials appear to be literally treading on a carpet of dead songbirds so thick that feet have not touched floor in nearly two years.
In an afterthought he realizes what the second spike might be:
addendum (post publication) another possibility just occurred to me: this second surge in severe outcomes might be associated with 4th doses (second booster). i have no data on prevalence or timing there, but if this is the cause, then we’d have real cause for alarm as it would imply that each incremental boost looks 5X worse than before. purely speculative, but perhaps fertile ground for inquiry.
In other VAERS news, Children's Health Defense reports the illicit deletion of 10,000 severe adverse reactions to COVID vaccines from the database.

P.S. In other vaccine news, the FDA rubber-stamped another booster today, this time for five-year-olds, without any clinical trials for efficacy, and with minimal safety data. It did not reconvene the advisory panel because the advisory panel already said not to do that.

Here at PlagueBlog Headquarters, we follow the science, not political decisions made by the FDA against scientific advice.

P.S. Massachusetts cases were up a quarter of a percent on Friday.

No comments: